注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Gelesis Holdings Inc是一家商業階段的生物治療公司,旨在促進消費者參與。該公司專注於推進用於慢性胃腸道(GI)疾病的超吸收性水凝膠療法,包括超重、二型糖尿病、非酒精性脂肪肝病(NAFLD)/非酒精性脂肪性肝炎(NASH)、功能性便秘(FC)和炎症性腸病。其產品Plenity是一種口服膠囊。Plenity可以通過遠程醫療諮詢獲得處方,與接受過體重管理支持培訓的醫生進行遠程醫療諮詢,並根據需要免費、無限制地進行隨訪。消費者可登陸myplenity.com進行在線諮詢。該公司的其他管道候選產品包括用於糖尿病前期和二型糖尿病減肥的GS200。其還正在開髮用於治療NAFLD和NASH的GS300,以及用於治療FC的GS500。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Louis J. Aronne | 66 | 2015 | Member of Scientific Advisory Board |
James Hill | - | - | Member of Scientific Advisory Board |
Allan Geliebter | - | - | Member of Scientific Advisory Board |
Hassan M. Heshmati | 70 | 2020 | Member of Scientific Advisory Board |
Angelo Tremblay | - | 2015 | Member of Scientific Advisory Board |
Caroline M. Apovian | - | - | Member of Scientific Advisory Board |
Alison Perry Bauerlein | 41 | 2022 | Independent Director |
Lee M. Kaplan | - | - | Member of Scientific Advisory Board |
Arne V. Astrup | - | - | Member of Scientific Advisory Board |
Ken Fujioka | - | 2015 | Member of Scientific Advisory Board |
Bennett M. Shapiro | 82 | - | Member of Scientific Advisory Board |
Clayton Christopher | 48 | - | Independent Director |
Jane Larsen Wildman | 60 | 2021 | Independent Director |
Paul R. Fonteyne | 62 | 2022 | Independent Director |
Kathryn E. Cavanaugh | 48 | 2022 | Independent Director |
Yishai Zohar | 60 | 2022 | Founder, President, CEO, Chief Compl. Officer, Secretary, Treasurer, Interim PFO and PAO & Director |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核